We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$148M
Turnover
14.17%
1-Year Est. Return
98.22%
This Fund
S&P 500
This Quarter
Est. Return
+65.5%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$47.5M
(+47%)
Cap. Flow
+$1.31M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
42.29%
Holding
113
New
6
Increased
40
Reduced
67
Closed
–
Avg Time Held
3.5
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXS Green Alpha ETF
NXTE
|
+$2.44M |
| 2 |
Beam Therapeutics
BEAM
|
+$229K |
| 3 |
Yeti Holdings
YETI
|
+$227K |
| 4 |
10x Genomics
TXG
|
+$219K |
| 5 |
Azenta
AZTA
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Horizon Technology Finance
HRZN
|
+$693K |
| 2 |
Lam Research
LRCX
|
+$365K |
| 3 |
Applied Materials
AMAT
|
+$184K |
| 4 |
Corning
GLW
|
+$172K |
| 5 |
Garmin
GRMN
|
+$89.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 62.33% |
| 2 | Healthcare | 12.52% |
| 3 | Industrials | 7.73% |
| 4 | Consumer Discretionary | 4.56% |
| 5 | Utilities | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$82B
| $213K | 0.14% |
341
+5
| +1% | +$3.4K |
2025 Q4
2 quarters
|
|
102
GitLab
GTLB
$8.92B
| $212K | 0.14% |
+6,937
| New | +$176K |
2026 Q2
0 quarters
|
|
103
Arcturus Therapeutics
ARCT
$308M
| $182K | 0.12% |
27,091
-1,047
| -4% | -$8.25K |
2025 Q1
5 quarters
|
|
104
AbCellera Biologics
ABCL
$3.95B
| $172K | 0.12% |
21,916
-1,028
| -4% | -$5.03K |
2021 Q3
19 quarters
|
|
105
Shoals Technologies Group
SHLS
$1.28B
| $161K | 0.11% |
16,247
+217
| +1% | +$1.97K |
2022 Q2
16 quarters
|
|
106
Ginkgo Bioworks
DNA
$749M
| $134K | 0.09% |
13,546
-230
| -2% | -$1.92K |
2023 Q1
13 quarters
|
|
107
Mobileye
MBLY
$6.23B
| $132K | 0.09% |
13,587
+121
| +0.9% | +$1.08K |
2023 Q3
11 quarters
|
|
108
DELISTED
ESS Tech
GWH
| $110K | 0.07% |
115,775
+1,195
| +1% | +$1.19K |
2023 Q3
11 quarters
|
|
109
Rapid7
RPD
$857M
| $82.9K | 0.06% |
+10,230
| New | +$67.8K |
2026 Q2
0 quarters
|
|
110
Inovio Pharmaceuticals
INO
$106M
| $74.9K | 0.05% |
68,055
+2,475
| +4% | +$2.94K |
2021 Q2
20 quarters
|
|
111
ECARX Holdings
ECX
$346M
| $67.3K | 0.05% |
52,202
+2,842
| +6% | +$3.24K |
2024 Q4
6 quarters
|
|
112
Beam Global
BEEM
$21.4M
| $52.7K | 0.04% |
40,505
+1,080
| +3% | +$1.66K |
2022 Q1
17 quarters
|
|
113
Quantum-Si Incorporated
QSI
$260M
| $40.6K | 0.03% |
45,921
+2,713
| +6% | +$2.58K |
2023 Q3
11 quarters
|
|
Similar funds
BM
LFWA
RLWM
ACM
BSTWA
NI
TWPM
AA
Green Alpha Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Green Alpha Advisors held 113 positions worth $149M, up 47% from $102M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Green Alpha Advisors's Q2 2026 filing shows 6 new, 40 increased and 67 reduced positions. Its largest new stake was Beam Therapeutics: 7,569 shares worth $260K. The largest sale was Horizon Technology Finance, an estimated $693K.
By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 56% a quarter earlier, followed by Healthcare and Industrials.
- Green Alpha Advisors's largest Q2 2026 buy was Beam Therapeutics: 7,569 shares worth $260K.
- Green Alpha Advisors added most to AXS Green Alpha ETF in Q2 2026, an estimated $2.44M increase.
- Green Alpha Advisors's biggest Q2 2026 reduction was Horizon Technology Finance, cutting an estimated $693K.
- Green Alpha Advisors's ten largest holdings make up 42% of its $149M portfolio in Q2 2026.
- Green Alpha Advisors opened 6 new positions and closed 0 in Q2 2026.
- Green Alpha Advisors's portfolio value rose 47% quarter-over-quarter to $149M.
Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.